Misop Han

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. pmc Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy
    Misop Han
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 2101, USA
    J Urol 188:2404-9. 2012
  2. pmc The impact of preoperative erectile dysfunction on survival after radical prostatectomy
    Misop Han
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    BJU Int 106:1612-7. 2010
  3. pmc Tandem-robot assisted laparoscopic radical prostatectomy to improve the neurovascular bundle visualization: a feasibility study
    Misop Han
    James Buchanan Brady Urological Institute, Urology Robotics Laboratory, Baltimore, Maryland 21287, USA
    Urology 77:502-6. 2011
  4. doi request reprint Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland
    Prostate 73:1673-80. 2013
  5. doi request reprint Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men
    Ashley E Ross
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA Electronic address
    Eur Urol 69:496-504. 2016
  6. pmc Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA
    BJU Int 112:751-7. 2013
  7. pmc A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 185:1691-7. 2011
  8. pmc Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy
    David J Hernandez
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 72:172-6. 2008
  9. pmc Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching
    Ahmed Magheli
    Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 72:1246-51. 2008
  10. doi request reprint Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy
    Phillip M Pierorazio
    Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Urol Oncol 31:589-94. 2013

Detail Information

Publications69

  1. pmc Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy
    Misop Han
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 2101, USA
    J Urol 188:2404-9. 2012
    ..However, to our knowledge it is unknown how accurately the freehand, transrectal ultrasound guided biopsy cores are placed in the prostate and how the geometric distribution of biopsy cores may affect the prostate cancer detection rate...
  2. pmc The impact of preoperative erectile dysfunction on survival after radical prostatectomy
    Misop Han
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    BJU Int 106:1612-7. 2010
    ..The underlying pathology for preoperative ED may adversely affect survival following radical prostatectomy (RP). We examined the association between preoperative ED and survival following RP...
  3. pmc Tandem-robot assisted laparoscopic radical prostatectomy to improve the neurovascular bundle visualization: a feasibility study
    Misop Han
    James Buchanan Brady Urological Institute, Urology Robotics Laboratory, Baltimore, Maryland 21287, USA
    Urology 77:502-6. 2011
    ..The accompanying blood vessels in the NVB can serve as a macroscopic landmark to localize the microscopic cavernous nerves in the NVB...
  4. doi request reprint Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland
    Prostate 73:1673-80. 2013
    ..We report the 30-year institutional experience of radical prostatectomy (RP) for men with clinically localized prostate cancer (PC) found to have lymph node (LN) metastases at surgery...
  5. doi request reprint Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men
    Ashley E Ross
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA Electronic address
    Eur Urol 69:496-504. 2016
    ..Current guidelines suggest adjuvant radiation therapy for men with adverse pathologic features (APFs) at radical prostatectomy (RP). We examine at-risk men treated only with RP until the time of metastasis...
  6. pmc Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA
    BJU Int 112:751-7. 2013
    ....
  7. pmc A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 185:1691-7. 2011
    ..We investigated outcomes in men with pT3b disease in the contemporary era...
  8. pmc Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy
    David J Hernandez
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 72:172-6. 2008
    ..We determined the incidence of biochemical recurrence (BR), local recurrence (LR), distant metastasis (DM), and prostate cancer-specific mortality (PCSM) among this low-risk cohort...
  9. pmc Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching
    Ahmed Magheli
    Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 72:1246-51. 2008
    ..To investigate the significance of body mass index (BMI) as an independent predictor of biochemical recurrence in men treated with surgery for clinically localized adenocarcinoma of the prostate...
  10. doi request reprint Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy
    Phillip M Pierorazio
    Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Urol Oncol 31:589-94. 2013
    ..We examine biopsy characteristics of men with high-grade PC at RP to better select those who may benefit from surgery...
  11. pmc African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
    Debasish Sundi
    Johns Hopkins University, Baltimore, MD, USA
    J Clin Oncol 31:2991-7. 2013
    ..To explore whether race-based health disparities exist among men with very low-risk PCa, we evaluated oncologic outcomes of AA men with very low-risk PCa who were candidates for AS but elected to undergo radical prostatectomy (RP)...
  12. pmc Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA
    BJU Int 112:45-53. 2013
    ..Specifically, it addresses approach-specific morbidities and indicates that MIRP is associated with higher rates of 'off-pathway' discharge, most often due to ileus...
  13. pmc An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011
    John B Eifler
    James Buchanan Brady Urological Institute and the Department of Urology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    BJU Int 111:22-9. 2013
    ..To update the 2007 Partin tables in a contemporary patient population...
  14. pmc Cigarette smoking and prostate cancer recurrence after prostatectomy
    Corinne E Joshu
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Natl Cancer Inst 103:835-8. 2011
    ..31, 95% confidence interval = 1.05 to 5.10). This result suggests an association between cigarette smoking and risk of prostate cancer recurrence...
  15. doi request reprint External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score
    Kevin H Zhao
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 72:396-400. 2008
    ..This study provides external validation and a modified version of the model using a large cohort of men treated with radical prostatectomy at a high-volume, tertiary referral center...
  16. pmc Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
    Bruce J Trock
    Brady Urological Institute, Johns Hopkins School of Medicine, 600 N Wolfe St, 546 Phipps Bldg, Baltimore, MD 21287, USA
    JAMA 299:2760-9. 2008
    ....
  17. pmc Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era
    Corinne E Joshu
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Rm E6137, Baltimore, MD 21205, USA
    Cancer Prev Res (Phila) 4:544-51. 2011
    ..Physical activity (≥ 5 h/wk) did not attenuate risk in men who gained more than 2.2 kg. By avoiding weight gain, men with prostate cancer may both prevent recurrence and improve overall well-being...
  18. doi request reprint The relationship between the extent of extraprostatic extension and survival following radical prostatectomy
    Byong Chang Jeong
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    Eur Urol 67:342-6. 2015
    ..Yet optimal criteria for staging, validation within a large cohort, and long-term follow-up are lacking...
  19. pmc Identification of men with the highest risk of early disease recurrence after radical prostatectomy
    Debasish Sundi
    Brady Institute of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland
    Prostate 74:628-36. 2014
    ..Men destined to have early biochemical recurrence (BCR) following radical prostatectomy (RP) may be optimal candidates for multimodal treatment. Here we identified pre-operative predictors of early BCR within a surgical cohort who recurred...
  20. doi request reprint Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system
    Adam C Reese
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21224, USA
    Urology 80:1075-9. 2012
    ..To analyze the National Comprehensive Cancer Network prostate cancer guidelines pretreatment risk groups in a contemporary series of patients treated with radical prostatectomy...
  21. pmc Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 110:1122-8. 2012
    ....
  22. ncbi request reprint Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003
    Masood A Khan
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Urology 62:86-91; discussion 91-2. 2003
    ..7% to 4%). Previous studies, mostly carried out before the PSA era, reported conflicting data with respect to cancer control for these younger men treated with RRP...
  23. pmc Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 76:715-21. 2010
    ..To evaluate the long-term outcomes of patients with high Gleason sum 8-10 at radical prostatectomy (RP) and to identify the predictors of prostate cancer-specific survival (CSS) in this cohort...
  24. doi request reprint Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenarians
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Baltimore, MD, USA
    BJU Int 106:791-5. 2010
    ....
  25. doi request reprint The significance of a positive bladder neck margin after radical prostatectomy: the American Joint Committee on Cancer Pathological Stage T4 designation is not warranted
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 183:151-7. 2010
    ..We examined biochemical recurrence-free survival and cancer specific survival in men with a positive bladder neck margin...
  26. pmc Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone
    David J Hernandez
    Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    BJU Int 103:609-14. 2009
    ....
  27. pmc Progression after radical prostatectomy for men in their thirties compared to older men
    Stacy Loeb
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    BJU Int 101:1503-6. 2008
    ..To assess the biochemical outcome after radical prostatectomy (RP) specifically for men aged 30-39 years, as previous studies suggest that prostate cancer in young men might be more aggressive...
  28. pmc Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancer
    Nilda Gonzalez-Roibon
    Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Int J Surg Pathol 21:352-7. 2013
    ..The latter was performed by comparing biochemical recurrence (BCR)-free survival in cases of periprostatic LN metastasis versus matched patients showing pelvic LN metastasis...
  29. pmc Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas
    Antoun Toubaji
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Mod Pathol 24:1511-20. 2011
    ..In summary, TMPRSS2-ERG fusion was not prognostic for recurrence after retropubic radical prostatectomy for clinically localized prostate cancer, although men with ERG gene copy number gain without fusion were twice more likely to recur...
  30. pmc Does laterality of positive needle biopsy in clinical T2a patients with prostate cancer affect biochemical recurrence-free survival?
    Ina Wu
    James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins Hospital, Baltimore, Maryland, USA
    Urology 72:1219-23. 2008
    ..To test whether patients with clinical Stage T2a prostate cancer with biopsy-proven disease only contralateral to the palpable abnormality experience outcomes similar to those of patients with clinical Stage T1c...
  31. doi request reprint Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era
    Jeffrey J Tosoian
    The James Buchanan Brady Urological Institute and Department of Urology at the Johns Hopkins University School of Medicine, Baltimore, MD, USA
    BJU Int . 2016
    ..To update the Partin Tables for prediction of pathological stage in the contemporary setting and examine trends in patients treated with radical prostatectomy (RP) over the past three decades...
  32. pmc A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
    Jonathan I Epstein
    The Johns Hopkins Medical Institutions, Baltimore, MD, USA Electronic address
    Eur Urol 69:428-35. 2016
    ..The lowest score, assigned 6, may be misunderstood as a cancer in the middle of the grading scale, and 3+4=7 and 4+3=7 are often considered the same prognostic group...
  33. doi request reprint SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort
    Michael H Johnson
    James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland
    J Urol 196:1436-1444. 2016
    ..Prostate cancer is clinically and molecularly heterogeneous. We determined the prognosis of men with ERG-ETS fusions and SPINK1 over expression...
  34. pmc Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature
    Farzana A Faisal
    Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA
    BJU Int 114:E120-9. 2014
    ....
  35. pmc Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literature
    Deborah R Kaye
    Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Curr Opin Urol 24:75-80. 2014
    ..To present the recent advances in needle guidance and robotic ultrasound technology which are used for prostate cancer (PCa) diagnosis and management...
  36. pmc Impact of surgical margin status on prostate-cancer-specific mortality
    Heather J Chalfin
    James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    BJU Int 110:1684-9. 2012
    ..In this cohort, men routinely did not receive adjuvant therapy, affording the unique opportunity to study the long-term implications of a PSM...
  37. pmc Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer
    Phillip M Pierorazio
    Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 109:988-93. 2012
    ....
  38. ncbi request reprint Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
    Misop Han
    James Buchanan Brady Urological Institute, Departments of Urology, Oncology and Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Urol 169:517-23. 2003
    ..We then used those indicators to develop multivariate models for determination of recurrence probability following radical retropubic prostatectomy...
  39. pmc Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy
    Ahmed Magheli
    Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Urol 179:1780-4; discussion 1784. 2008
    ..We investigated whether prostate specific antigen density yielded an advantage over total prostate specific antigen for predicting adverse pathological characteristics and disease recurrence following radical prostatectomy...
  40. ncbi request reprint A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria
    Matthew B Gretzer
    The James Buchanan Brady Urological Institute, The Johns Hopkins University Medical Institutions, Baltimore, Maryland, USA
    J Urol 168:1419-22. 2002
    ..We evaluate how the American Society for Therapeutic Radiation and Oncology (ASTRO) criteria affect the interpretation of failure when applied to radical prostatectomy...
  41. doi request reprint New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer
    Won Sik Ham
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea
    Eur Urol . 2016
    ..However, BCR does not necessarily portend worse survival outcomes...
  42. pmc Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy
    Sheila F Faraj
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America
    PLoS ONE 11:e0146189. 2016
    ....
  43. doi request reprint Obesity and long-term survival after radical prostatectomy
    Heather J Chalfin
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, Seoul National University Boramae Hospital SBL, Seoul, South Korea Sungkyunkwan University Samsung Medical Center BCJ, Seoul, South Korea Duke University Medical Center, Durham, North Carolina SJF
    J Urol 192:1100-4. 2014
    ....
  44. doi request reprint Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis
    Adam C Reese
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland Electronic address
    J Urol 190:2033-8. 2013
    ..15 ng/ml, biopsy Gleason score 6 or less, 2 or fewer positive biopsy cores and 50% or less involvement of any biopsy core. We hypothesized that these criteria may be excessively strict, precluding many men from active surveillance...
  45. doi request reprint Radical prostatectomy outcome in men 65 years old or older with low risk prostate cancer
    Jeffrey K Mullins
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Urol 187:1620-5. 2012
    ..We examined the proportion and outcomes of men 65 years old or older with low risk disease who underwent radical prostatectomy at our institution...
  46. doi request reprint Causes of death after radical prostatectomy at a large tertiary center
    John Bernard Eifler
    James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 188:798-801. 2012
    ..We evaluated the cause of death in a large series of patients who underwent radical prostatectomy and compared the rate of death to that of the general American population...
  47. ncbi request reprint An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series
    Misop Han
    Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 171:23-6. 2004
    ....
  48. doi request reprint Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series
    Mark W Ball
    Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    BJU Int . 2016
    ..To assess factors associated with lymphatic drainage and lymph node (LN) metastasis to the prostatic anterior fat pad (PAFP) in men with prostate cancer and the utility of routine PAFP analysis at the time of radical prostatectomy (RP)...
  49. pmc Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy
    Jeffrey J Tosoian
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Eur Urol . 2016
    ..25, 95% confidence interval [CI] 1.33-3.82) and metastasis (HR 3.90, 95% CI 1.46-10.4) in multivariable models...
  50. pmc Risk Factors for Intraprostatic Incision into Malignant Glands at Radical Prostatectomy
    Sung Woo Park
    The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA Department of Urology, Pusan National University Yangsan Hospital, Yangsan, South Korea Electronic address
    Eur Urol 68:311-6. 2015
    ..Histologically identified intraprostatic incision (IPI) into malignant glands is associated with an increase in biochemical recurrence following radical prostatectomy (RP). However, the predictor of IPI is poorly evaluated...
  51. pmc PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
    Tamara L Lotan
    1 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA 2 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Mod Pathol 28:128-37. 2015
    ..These data provide evidence that a genetic event can improve Gleason score accuracy and highlight a path toward the clinical use of molecular markers to augment pathologic grading...
  52. doi request reprint Ultrasound probe and needle-guide calibration for robotic ultrasound scanning and needle targeting
    Chunwoo Kim
    theUrology Robotics Laboratory, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    IEEE Trans Biomed Eng 60:1728-34. 2013
    ..Targeting accuracy is sufficient for targeting small, clinically significant prostatic cancer lesions, but actual in vivo targeting will include additional error components that will have to be determined...
  53. doi request reprint Critical appraisal of management of rectal injury during radical prostatectomy
    Wilmer B Roberts
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21224, USA
    Urology 76:1088-91. 2010
    ..To critically evaluate the perioperative management of rectal injury during radical prostatectomy...
  54. ncbi request reprint Contemporary evaluation of the D'amico risk classification of prostate cancer
    David J Hernandez
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 70:931-5. 2007
    ..We studied the performance and clinical relevance of this classification system over time, in the context of the stage migration seen in the contemporary era, using data from a high-volume, tertiary referral center...
  55. pmc Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery
    Alison M Mondul
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
    J Urol 185:1268-73. 2011
    ..Thus, we evaluated the association of statin use with pathological tumor characteristics and prostate cancer recurrence after prostatectomy in a retrospective cohort...
  56. ncbi request reprint Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center
    Matthew E Nielsen
    Department of Urology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    J Urol 176:515-9. 2006
    ..To address this issue we examined the outcomes of a cohort of black and white men treated by multiple surgeons at our institution...
  57. ncbi request reprint Geometric systematic prostate biopsy
    Doyoung Chang
    a Robotics Laboratory, Urology Department, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    Minim Invasive Ther Allied Technol . 2016
    ..The study objective was to determine the influence of the geometric distribution of the cores on the detection probability of prostate cancer (PCa)...
  58. doi request reprint Variability in Medicare utilization and payment among urologists
    Joan S Ko
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Md Electronic address
    Urology 85:1045-50. 2015
    ....
  59. pmc Prediction of mortality after radical prostatectomy by Charlson comorbidity index
    Thomas J Guzzo
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Urology 76:553-7. 2010
    ..We evaluated the association between perioperative comorbidity and risk of death from causes other than prostate cancer in men who underwent radical prostatectomy (RP)...
  60. doi request reprint Practice patterns and individual variability of surgeons performing radical prostatectomy at a high volume academic center
    Hiten D Patel
    Center for Surgical Trials and Outcomes Research, Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland Electronic address
    J Urol 193:812-9. 2015
    ..We hypothesized that individual practice variability would be minimal among urologists practicing at a high volume academic center...
  61. pmc Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study
    Kenneth S Tseng
    From the Department of Anesthesiology, The Mount Sinai Medical Center, New York, NY Departments of Anesthesiology and Urology, The Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Baltimore, MD
    Reg Anesth Pain Med 39:284-8. 2014
    ..We examine the correlation of a spinal anesthesia-only technique on prostate cancer recurrence...
  62. pmc Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence
    Paul J Dluzniewski
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA
    Cancer Epidemiol Biomarkers Prev 21:1774-82. 2012
    ....
  63. pmc PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients
    Tamara L Lotan
    Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Clin Cancer Res 17:6563-73. 2011
    ....
  64. pmc Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer
    Rong Hu
    Department of Urology, Oncology, and Pathology, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Cancer Res 69:16-22. 2009
    ..In addition, as expression markers for lethal PCa, these novel AR variants may be explored as potential biomarkers and therapeutic targets for advanced PCa...
  65. doi request reprint Importance of Reporting the Gleason Score at the Positive Surgical Margin Site: Analysis of 4,082 Consecutive Radical Prostatectomy Cases
    Max Kates
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland Electronic address
    J Urol 195:337-42. 2016
    ....
  66. pmc ¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
    Steven P Rowe
    The Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland
    J Nucl Med 56:1003-10. 2015
    ..An imaging biomarker able to detect clinically significant high-grade primary prostate cancer reliably would address an unmet clinical need by allowing for risk-adapted patient management...
  67. ncbi request reprint Nomograms for clinically localized prostate cancer. Part I: radical prostatectomy
    Misop Han
    James Buchanan Brady Urological Institute, The Department of Urology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Semin Urol Oncol 20:123-30. 2002
    ..These nomograms can help patients understand the long-term cancer cure rates after radical prostatectomy...
  68. pmc Imaging guidance in minimally invasive prostatectomy
    Angela D Gupta
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Urol Oncol 29:343-6. 2011
    ..The purpose of this article is to review different imaging modalities that have been developed with a goal of further improving the surgical outcomes in minimally invasive prostatectomy...
  69. pmc Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer
    Wilmer B Roberts
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Marburg 1, Baltimore, MD 21205, USA
    Surg Oncol 18:268-74. 2009
    ..We investigated the significance of biochemical recurrence after definitive therapy and the available salvage therapy options for cancer recurrence...